Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- 8-K Current report
- 5.1 Exhibit 5.1
- 10.1 Exhibit 10.1
- 10.2 Exhibit 10.2
- 10.3 Exhibit 10.3
- 10.4 Exhibit 10.4
- 99.1 Navidea Biopharmaceuticals, Inc. Announces Intent to sell Cardinal Milestone Payment for $8 Million; Secures New $2.75 Million Equity Line of Credit
- Download Excel data file
- View Excel data file
NAVB similar filings
- 16 Jun 23 Navidea Biopharmaceuticals, Inc. Announces Distribution of Series K Preferred Stock to Holders of its Common Stock
- 2 Jun 23 Entry into a Material Definitive Agreement
- 25 May 23 Entry into a Material Definitive Agreement
- 28 Apr 23 Navidea Biopharmaceuticals, Inc. Announces Intent to sell Cardinal Milestone Payment for $8 Million; Secures New $2.75 Million Equity Line of Credit
- 13 Apr 23 Navidea Biopharmaceuticals, Inc. Enters Asset Purchase Agreement with Meilleur Technologies, Inc. for Rights to NAV4694
- 31 Mar 23 Departure of Directors or Certain Officers
- 21 Mar 23 Navidea Biopharmaceuticals Reports Fourth Quarter 2022 Financial Results
Filing view
External links